NCT02585492

Brief Summary

The purpose of this study is to determine if the position of the mother in the first two hours after delivery, while she is in skin to skin contact with your child, influences the oxygen saturation and/or heart rate of the newborn. In this way it could provide some useful information for the prevention of seemingly lethal episodes or sudden death of the child when, following current recommendations is skin to skin contact in the first hours of life. These episodes are communicating in all developed countries and have caused great concern and interest in the scientific community. So far we only have information from case series.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,243

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2015

Typical duration for not_applicable

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 22, 2015

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 23, 2015

Completed
9 days until next milestone

Study Start

First participant enrolled

November 1, 2015

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

October 29, 2018

Status Verified

October 1, 2018

Enrollment Period

2.4 years

First QC Date

October 22, 2015

Last Update Submit

October 26, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Presence of at least one episode desaturation ≤90%

    The evaluation will be done with a pulse oximeter (non-invasive Radical-7 Signal Extraction PulseCO-Oximeter equipped with Masimo Rainbow SET technology). All the technology used in all hospitals is part of Masimo's SafeyNet system.

    Two first hours after delivery

Study Arms (2)

head-of-bed elevated 15°

ACTIVE COMPARATOR

Mother's head-of-bead elevated 15°. Intervention: Head-of-bed elevated 15° during 2 hours after the delivery.

Other: Head-of-bed elevated 15°

head-of-bed elevated 45°

EXPERIMENTAL

Mother's head-of-bead elevated 45°. Intervention: Head-of-bed elevated 45°during 2 hours after delivery.

Other: Head-of-bed elevated 45°

Interventions

Head-of-bed elevated 15° during 2 hours after delivery.

head-of-bed elevated 15°

Head-of-bed elevated 45° during 2 hours after delivery.

head-of-bed elevated 45°

Eligibility Criteria

Age259 Days - 293 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Single fetus pregnancy
  • Pregnancy controlled or partially controlled(1)
  • Normal pregnancy or with gestational diabetes treated with diet, high blood pressure controlled with only a drug as maximum (without preeclampsia)
  • Gestation to term (between 37 weeks to 41 weeks and 6 days of gestational age).
  • Maternal temperature at onset of labor ≤38 degrees Celsius
  • Presence of a companion during the 2 hours after delivery
  • Desire of the mother to perform early skin-to-skin

You may not qualify if:

  • Consumption of tobacco, alcohol, drugs or any medication with sedative or relaxing(2) effect or any pathology during pregnancy.
  • Prenatal diagnosis of chromosomal abnormalities or major malformations.
  • Prenatal diagnosis of intrauterine growth restriction with any degree of alteration in the flow as well as the abnormal small-for-gestational-age fetuses (due to malformations, intrauterine infection ...).
  • No companion during the first two hours postpartum
  • Notes:
  • Partially controlled pregnancy: she has the 20 weeks ultrasound but lack the first and/or third trimester of pregnancy and/or analytical (serology, O'Sullivan test ...).
  • Medicinal products with sedative or relaxing effect: opioids, anticonvulsants, antipsychotics, benzodiazepines, anxiolytics, hypnotics, antidepressants and sedative plants.
  • Related to childbirth:
  • Caesarean section or instrumental delivery (forceps, vacuum)
  • Maternal fever \>38 degrees Celsius
  • Mother hemodynamic instability (hypotension, tachycardia, altered level of consciousness, poor perfusion, striking pallor)
  • Cord prolapse
  • Signs of fetal distress with lower pH fetal scalp \<7.25 or umbilical artery pH \<7.20
  • Any other obstetrical complication
  • Related mother:
  • +19 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Hospital Universitario Severo Ochoa

Leganés, Madrid, 28911, Spain

Location

Hospital Universitario de Cruces

Bilbao, Vizcaya, 48903, Spain

Location

Hospital de Vielha

Lleida, 25530, Spain

Location

Hospital Universitario 12 de Octubre

Madrid, 28041, Spain

Location

Hospital Universitario La Paz

Madrid, 28046, Spain

Location

Hospital Universitario Quirón

Madrid, 28223, Spain

Location

Hospital La Fe

Valencia, 46022, Spain

Location

Related Publications (1)

  • Rodriguez Lopez J, Garcia Lara NR, Lopez Maestro M, De la Cruz Bertolo J, Martinez Avila JC, Vento M, Parra Llorca A, Izquierdo Macian I, Pellicer A, Marin Huarte N, Asla Elorriaga I, Roman Echevarria L, Copons Fernandez C, Martin Ancel A, Cabanas F, Garcia Algar O, Pallas Alonso CR. What is the impact of mother's bed incline on episodes of decreased oxygen saturation in healthy newborns in skin-to-skin contact after delivery: Study protocol for a randomized controlled trial. Trials. 2019 Mar 20;20(1):179. doi: 10.1186/s13063-019-3256-0.

MeSH Terms

Conditions

Infant, Newborn, Diseases

Condition Hierarchy (Ancestors)

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Nadia R. García Lara, Dra

    Hospital Universitario 12 de Octubre

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 22, 2015

First Posted

October 23, 2015

Study Start

November 1, 2015

Primary Completion

April 1, 2018

Study Completion

April 1, 2018

Last Updated

October 29, 2018

Record last verified: 2018-10

Data Sharing

IPD Sharing
Will not share

Locations